MDXXF
Price
$0.10
Change
-$0.01 (-9.09%)
Updated
Aug 7 closing price
Capitalization
10.42M
TRML
Price
$21.06
Change
+$0.34 (+1.64%)
Updated
Aug 11, 04:59 PM (EDT)
Capitalization
532.27M
Interact to see
Advertisement

MDXXF vs TRML

Header iconMDXXF vs TRML Comparison
Open Charts MDXXF vs TRMLBanner chart's image
PharmAla Biotech Holdings
Price$0.10
Change-$0.01 (-9.09%)
Volume$23.9K
Capitalization10.42M
Tourmaline Bio
Price$21.06
Change+$0.34 (+1.64%)
Volume$1.41K
Capitalization532.27M
MDXXF vs TRML Comparison Chart in %
Loading...
MDXXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRML
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MDXXF vs. TRML commentary
Aug 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDXXF is a Hold and TRML is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 12, 2025
Stock price -- (MDXXF: $0.10 vs. TRML: $20.72)
Brand notoriety: MDXXF and TRML are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MDXXF: 80% vs. TRML: 84%
Market capitalization -- MDXXF: $10.42M vs. TRML: $532.27M
MDXXF [@Biotechnology] is valued at $10.42M. TRML’s [@Biotechnology] market capitalization is $532.27M. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MDXXF’s FA Score shows that 0 FA rating(s) are green whileTRML’s FA Score has 1 green FA rating(s).

  • MDXXF’s FA Score: 0 green, 5 red.
  • TRML’s FA Score: 1 green, 4 red.
According to our system of comparison, TRML is a better buy in the long-term than MDXXF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MDXXF’s TA Score shows that 5 TA indicator(s) are bullish while TRML’s TA Score has 5 bullish TA indicator(s).

  • MDXXF’s TA Score: 5 bullish, 4 bearish.
  • TRML’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, MDXXF is a better buy in the short-term than TRML.

Price Growth

MDXXF (@Biotechnology) experienced а +30.04% price change this week, while TRML (@Biotechnology) price change was -4.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +22.22%. For the same industry, the average monthly price growth was +31.78%, and the average quarterly price growth was +19.63%.

Industries' Descriptions

@Biotechnology (+22.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRML($532M) has a higher market cap than MDXXF($10.4M). TRML YTD gains are higher at: 2.170 vs. MDXXF (-42.363). MDXXF has higher annual earnings (EBITDA): -1.86M vs. TRML (-98.41M). TRML has more cash in the bank: 249M vs. MDXXF (1.25M). MDXXF has higher revenues than TRML: MDXXF (421K) vs TRML (0).
MDXXFTRMLMDXXF / TRML
Capitalization10.4M532M2%
EBITDA-1.86M-98.41M2%
Gain YTD-42.3632.170-1,953%
P/E RatioN/AN/A-
Revenue421K0-
Total Cash1.25M249M1%
Total DebtN/A196K-
TECHNICAL ANALYSIS
Technical Analysis
MDXXFTRML
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
78%
MACD
ODDS (%)
N/A
Bearish Trend 4 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
88%
Advances
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 13 days ago
85%
Declines
ODDS (%)
Bearish Trend 28 days ago
90%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
84%
Aroon
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
MDXXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRML
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TWCAX124.171.10
+0.89%
American Century Select A
RYMAX50.940.31
+0.61%
Rydex Telecommunications H
PMDIX18.950.05
+0.26%
Principal Small-MidCap Dividend Inc Inst
HMCLX14.820.03
+0.20%
Harbor Mid Cap Institutional
CFWIX30.36-0.02
-0.07%
Calvert Global Water I

MDXXF and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDXXF has been loosely correlated with NICXF. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if MDXXF jumps, then NICXF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDXXF
1D Price
Change %
MDXXF100%
N/A
NICXF - MDXXF
45%
Loosely correlated
N/A
ZIVO - MDXXF
22%
Poorly correlated
N/A
NGNE - MDXXF
20%
Poorly correlated
-1.12%
TRML - MDXXF
13%
Poorly correlated
-2.86%
ABVX - MDXXF
12%
Poorly correlated
+0.16%
More

TRML and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRML has been loosely correlated with IMNM. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if TRML jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRML
1D Price
Change %
TRML100%
-2.86%
IMNM - TRML
45%
Loosely correlated
-1.82%
STOK - TRML
44%
Loosely correlated
-1.13%
IDYA - TRML
43%
Loosely correlated
+3.08%
SYRE - TRML
42%
Loosely correlated
N/A
CRNX - TRML
42%
Loosely correlated
-3.69%
More